Patrick Wood
Stock Analyst at Morgan Stanley
(3.12)
# 1,185
Out of 4,960 analysts
104
Total ratings
48.72%
Success rate
1.8%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALC Alcon | Maintains: Equal-Weight | $84 → $80 | $82.02 | -2.46% | 5 | Aug 21, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $196 → $197 | $199.66 | -1.33% | 5 | Aug 11, 2025 | |
| STE STERIS | Maintains: Overweight | $276 → $295 | $251.87 | +17.12% | 7 | Aug 8, 2025 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $115 → $123 | $119.85 | +2.63% | 2 | Aug 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $12 → $13 | $14.94 | -12.99% | 8 | Aug 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $78 → $74 | $75.22 | -1.62% | 7 | Jul 31, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $71 → $68 | $41.23 | +64.93% | 3 | Jul 15, 2025 | |
| EW Edwards Lifesciences | Maintains: Equal-Weight | $75 → $81 | $81.83 | -1.01% | 9 | Jul 15, 2025 | |
| DXCM DexCom | Maintains: Equal-Weight | $82 → $89 | $82.26 | +8.19% | 8 | Jul 15, 2025 | |
| BAX Baxter International | Maintains: Underweight | $28 → $27 | $24.54 | +10.02% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $20 → $9 | $9.28 | -3.02% | 2 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $80 → $103 | $73.55 | +40.04% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $125 | $106.17 | +17.74% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $110 → $72 | $94.15 | -23.53% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $129.42 | +33.67% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $45 → $22 | $11.93 | +84.41% | 4 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $104 → $102 | $75.22 | +35.60% | 5 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $330.77 | -4.16% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $6.74 | +48.37% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $27.85 | +32.85% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $140.36 | - | 5 | Dec 11, 2017 |
Alcon
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $84 → $80
Current: $82.02
Upside: -2.46%
Becton, Dickinson and Company
Aug 11, 2025
Maintains: Overweight
Price Target: $196 → $197
Current: $199.66
Upside: -1.33%
STERIS
Aug 8, 2025
Maintains: Overweight
Price Target: $276 → $295
Current: $251.87
Upside: +17.12%
TransMedics Group
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $115 → $123
Current: $119.85
Upside: +2.63%
Bausch + Lomb
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $14.94
Upside: -12.99%
GE HealthCare Technologies
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $78 → $74
Current: $75.22
Upside: -1.62%
PROCEPT BioRobotics
Jul 15, 2025
Maintains: Overweight
Price Target: $71 → $68
Current: $41.23
Upside: +64.93%
Edwards Lifesciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $81.83
Upside: -1.01%
DexCom
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $82 → $89
Current: $82.26
Upside: +8.19%
Baxter International
Jul 15, 2025
Maintains: Underweight
Price Target: $28 → $27
Current: $24.54
Upside: +10.02%
Jul 15, 2025
Downgrades: Equal-Weight
Price Target: $20 → $9
Current: $9.28
Upside: -3.02%
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $73.55
Upside: +40.04%
May 16, 2025
Maintains: Overweight
Price Target: $120 → $125
Current: $106.17
Upside: +17.74%
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $94.15
Upside: -23.53%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $129.42
Upside: +33.67%
Mar 5, 2025
Downgrades: Equal-Weight
Price Target: $45 → $22
Current: $11.93
Upside: +84.41%
Dec 6, 2024
Maintains: Equal-Weight
Price Target: $104 → $102
Current: $75.22
Upside: +35.60%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $330.77
Upside: -4.16%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $6.74
Upside: +48.37%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $27.85
Upside: +32.85%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $140.36
Upside: -